| pubmed-article:10834429 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10834429 | lifeskim:mentions | umls-concept:C0577559 | lld:lifeskim |
| pubmed-article:10834429 | lifeskim:mentions | umls-concept:C1293122 | lld:lifeskim |
| pubmed-article:10834429 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10834429 | lifeskim:mentions | umls-concept:C0246689 | lld:lifeskim |
| pubmed-article:10834429 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
| pubmed-article:10834429 | lifeskim:mentions | umls-concept:C1256369 | lld:lifeskim |
| pubmed-article:10834429 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:10834429 | pubmed:dateCreated | 2000-9-6 | lld:pubmed |
| pubmed-article:10834429 | pubmed:abstractText | Repaglinide is a new oral hypoglycemic agent that acts as a prandial glucose regulator proposed for the treatment of type 2 diabetes by stimulating insulin secretion. The aim of this study was to explore actions of repaglinide on the rapid pulsatile insulin release by high-frequency insulin sampling and analysis of insulin-concentration time series. | lld:pubmed |
| pubmed-article:10834429 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10834429 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10834429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10834429 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10834429 | pubmed:month | May | lld:pubmed |
| pubmed-article:10834429 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:10834429 | pubmed:author | pubmed-author:VeldhuisJ DJD | lld:pubmed |
| pubmed-article:10834429 | pubmed:author | pubmed-author:SchmittAA | lld:pubmed |
| pubmed-article:10834429 | pubmed:author | pubmed-author:PincusSS | lld:pubmed |
| pubmed-article:10834429 | pubmed:author | pubmed-author:JuhlC BCB | lld:pubmed |
| pubmed-article:10834429 | pubmed:author | pubmed-author:SturisJJ | lld:pubmed |
| pubmed-article:10834429 | pubmed:author | pubmed-author:DejgaardAA | lld:pubmed |
| pubmed-article:10834429 | pubmed:author | pubmed-author:PørksenNN | lld:pubmed |
| pubmed-article:10834429 | pubmed:author | pubmed-author:HollingdalMM | lld:pubmed |
| pubmed-article:10834429 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10834429 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:10834429 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10834429 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10834429 | pubmed:pagination | 675-81 | lld:pubmed |
| pubmed-article:10834429 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:meshHeading | pubmed-meshheading:10834429... | lld:pubmed |
| pubmed-article:10834429 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10834429 | pubmed:articleTitle | Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. | lld:pubmed |
| pubmed-article:10834429 | pubmed:affiliation | Department of Medicine M (Endocrinology & Diabetes), Arhus Kommunehospital, University Hospital of Arhus, Denmark. cbj@dadlnet.dk | lld:pubmed |
| pubmed-article:10834429 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10834429 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10834429 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10834429 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:10834429 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
